Corning Incorporated and ATCC today extended an existing collaboration that will benefit cell culture researchers worldwide. Under terms of the agreement, Corning Life Sciences and ATCC will co-develop new applications for existing ATCC and Corning cell biology products; provide researchers with increased access to knowledgeable field scientists and information; and participate in joint marketing initiatives.
“We are excited to expand our relationship with ATCC,” said Brian Douglass, business director, Cell Culture, Corning Life Sciences. “Through our continued work, customers will have quicker access to more resources, information, and technical approaches to accelerate their research.”
Together, ATCC and Corning both offer a wealth of cell culture knowledge and information that researchers can access to improve productivity. Additionally, new application development for existing ATCC cells — primary, iPSCs, and hTERT immortalized cell lines—will provide improved workflow and new insights into ways Corning’s differentiated products, such as Corning® Matrigel®, can improve performance.
“We continually strive to acquire, authenticate, preserve, develop, standardize, and distribute biological materials and information for the advancement of scientific research,” said Matthew Klusas, senior director, Corporate Development, ATCC. “This collaboration with Corning Life Sciences helps us further accomplish that mission by providing our customers with value-added cell culture solutions.”
Through acquisition and ongoing R&D investment, Corning offers a leading portfolio of premium, innovative laboratory products and solutions for a wide spectrum of life science applications. Corning’s trusted quality brands, backed by technical expertise, provide researchers with better ways to advance their research from the beginning of their process to the end. The family of brands includes Corning®, PYREX®, Falcon®, Axygen®, and Gosselin™.